{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:34:21Z","timestamp":1789904061886,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jocn.2012.11.007","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T19:30:27Z","timestamp":1373484627000},"page":"1371-1376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["An immunohistochemical study of increased tumor necrosis factor-\u03b1 in the skin of patients with amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Hiroyuki","family":"Fukazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Tsukie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Higashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiitsu","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2012.11.007_b0005","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1212\/WNL.36.7.948","article-title":"Amyotrophic lateral sclerosis: histological, histochemical, and ultrastructural abnormalities of skin","volume":"36","author":"Ono","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.11.007_b0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jnnp.57.1.94","article-title":"Elastin cross-linking in the skin from patients with amyotrophic lateral sclerosis","volume":"57","author":"Ono","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2012.11.007_b0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1212\/WNL.51.2.399","article-title":"Alterations of skin glycosaminoglycans in patients with ALS","volume":"51","author":"Ono","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.11.007_b0020","first-page":"367","article-title":"Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis","volume":"122","author":"Suzuki","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2012.11.007_b0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jocn.2011.05.044","article-title":"Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis","volume":"19","author":"Ishikawa","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2012.11.007_b0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0140-6736(76)90517-1","article-title":"Amyotrophic lateral sclerosis and bedsores","volume":"1","author":"Furukawa","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2012.11.007_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-437X(96)90008-8","article-title":"Recent advances in tumor necrosis factor and CD40 signaling","volume":"6","author":"Tewari","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jocn.2012.11.007_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-5699(92)90116-O","article-title":"Two TNF receptors","volume":"13","author":"Tartaglia","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.jocn.2012.11.007_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2004.11.014","article-title":"TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition","volume":"1034","author":"Zou","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2012.11.007_b0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000049024","article-title":"Tumor necrosis factor and motoneuronal degeneration: an open problem","volume":"9","author":"Ghezzi","year":"2001","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jocn.2012.11.007_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2003.12.022","article-title":"Cytokines role in neurodegenerative events","volume":"149","author":"Viviani","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jocn.2012.11.007_b0060","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1046\/j.1460-9568.2000.00240.x","article-title":"Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS","volume":"12","author":"Terrado","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jocn.2012.11.007_b0065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s11064-007-9564-x","article-title":"Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India","volume":"33","author":"Babu","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jocn.2012.11.007_b0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/17482960802709416","article-title":"Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial","volume":"10","author":"Stommel","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.jocn.2012.11.007_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jocn.2012.11.007_b0080","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1212\/WNL.47.4_Suppl_2.63S","article-title":"Neuropathology of ALS: an overview","volume":"47","author":"Hirano","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.11.007_b0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.288.5464.335","article-title":"Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model","volume":"288","author":"Li","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jocn.2012.11.007_b0090","first-page":"139","article-title":"Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration","volume":"9","author":"Ghezzi","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jocn.2012.11.007_b0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1471-4159.2002.00968.x","article-title":"Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis","volume":"82","author":"Hensley","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2012.11.007_b0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0169-328X(01)00242-X","article-title":"Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis","volume":"95","author":"Elliott","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jocn.2012.11.007_b0105","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.11.007_b0110","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional status is a prognostic factor for survival in patients with ALS","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2012.11.007_b0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.PHM.0000052588.28912.A4","article-title":"Nutritional assessment of patients with neuromuscular diseases","volume":"82","author":"Pessolano","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.jocn.2012.11.007_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2012.11.007_b0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jocn.2012.11.007_b0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1523\/JNEUROSCI.4032-05.2006","article-title":"Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity","volume":"26","author":"Turrin","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2012.11.007_b0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/35094583","article-title":"Cytokines and acute neurodegeneration","volume":"2","author":"Allan","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jocn.2012.11.007_b0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0197-0186(00)00119-4","article-title":"An in vitro model for the study of microglia-induced neurodegeneration: involvement of nitric oxide and tumor necrosis factor-alpha","volume":"38","author":"Hemmer","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jocn.2012.11.007_b0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm0198-078","article-title":"TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination","volume":"4","author":"Liu","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2012.11.007_b0150","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jocn.2012.11.007_b0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/89490","article-title":"CXCR4-activated astrocyte glutamate release via TNF-\u03b1: amplification by microglia triggers neurotoxicity","volume":"4","author":"Bezzi","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jocn.2012.11.007_b0160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0304-3940(00)01177-0","article-title":"Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis","volume":"287","author":"Poloni","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2012.11.007_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0165-5728(02)00141-8","article-title":"Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro","volume":"128","author":"He","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2012.11.007_b0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0008-8749(86)90009-2","article-title":"Intracellular epidermal interleukin 1-like factors in the human epidermoid carcinoma cell line A431","volume":"100","author":"Hauser","year":"1986","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jocn.2012.11.007_b0175","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2340\/00015555-0747","article-title":"Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors","volume":"89","author":"Haslund","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jocn.2012.11.007_b0180","first-page":"325","article-title":"Keratinocytes: key immunocytes of the integument","volume":"143","author":"Nickoloff","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jocn.2012.11.007_b0185","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.172.6.1609","article-title":"Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light","volume":"172","author":"K\u00f6ck","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jocn.2012.11.007_b0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-481X.2006.00233.x","article-title":"Topical application of the tumour necrosis factor-\u03b1 antibody infliximab improves healing of chronic wounds","volume":"3","author":"Streit","year":"2006","journal-title":"Int Wound J"},{"key":"10.1016\/j.jocn.2012.11.007_b0195","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.09.012","article-title":"Tumor necrosis factor-alfa in nonhealing venous leg ulcers","volume":"60","author":"Charles","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586813000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T13:28:42Z","timestamp":1539523722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586813000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0967586813000738"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2012.11.007","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immunohistochemical study of increased tumor necrosis factor-\u03b1 in the skin of patients with amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2012.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}